Medical Care
Global Generic Drug CRO (Contract Research Organisation) Market Research Report 2025
- May 12, 25
- ID: 237524
- Pages: 81
- Figures: 90
- Views: 1
The global market for Generic Drug CRO (Contract Research Organisation) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
CRO (Contract Research Organization) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence.
Generic drug CRO is a CRO company that provides generic drug development services. In terms of generic drugs, CRO companies mainly provide services such as pharmaceutical research (raw material research, preparation research), clinical BE trials, and registration and marketing.
North American market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Generic Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Generic Drug CRO (Contract Research Organisation) include Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO, Hangzhou Bio-Sincerity Pharma-Tech, Wanbang Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Generic Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drug CRO (Contract Research Organisation).
The Generic Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Worldwide Clinical Trials
Eurofins Scientific
Celerion
Alliance Pharma
Accelsiors
Innovind Pharma
Avivia
SUNNOVO
Hangzhou Bio-Sincerity Pharma-Tech
Wanbang Biopharma
Guangzhou Boji Medical & Biotechnological
Xinjiang Bai Hua Cun Pharma Tech
Shandong Bestcomm Pharmaceutical
Segment by Type
Pharmaceutical Research
BE Test
Segment by Application
Pharmaceutical Companies
MAH Customer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drug CRO (Contract Research Organisation) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CRO (Contract Research Organization) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence.
Generic drug CRO is a CRO company that provides generic drug development services. In terms of generic drugs, CRO companies mainly provide services such as pharmaceutical research (raw material research, preparation research), clinical BE trials, and registration and marketing.
North American market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Generic Drug CRO (Contract Research Organisation) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Generic Drug CRO (Contract Research Organisation) in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Generic Drug CRO (Contract Research Organisation) include Worldwide Clinical Trials, Eurofins Scientific, Celerion, Alliance Pharma, Accelsiors, Innovind Pharma, Avivia, SUNNOVO, Hangzhou Bio-Sincerity Pharma-Tech, Wanbang Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Generic Drug CRO (Contract Research Organisation), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drug CRO (Contract Research Organisation).
The Generic Drug CRO (Contract Research Organisation) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Generic Drug CRO (Contract Research Organisation) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Drug CRO (Contract Research Organisation) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Worldwide Clinical Trials
Eurofins Scientific
Celerion
Alliance Pharma
Accelsiors
Innovind Pharma
Avivia
SUNNOVO
Hangzhou Bio-Sincerity Pharma-Tech
Wanbang Biopharma
Guangzhou Boji Medical & Biotechnological
Xinjiang Bai Hua Cun Pharma Tech
Shandong Bestcomm Pharmaceutical
Segment by Type
Pharmaceutical Research
BE Test
Segment by Application
Pharmaceutical Companies
MAH Customer
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Drug CRO (Contract Research Organisation) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Research
1.2.3 BE Test
1.3 Market by Application
1.3.1 Global Generic Drug CRO (Contract Research Organisation) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 MAH Customer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug CRO (Contract Research Organisation) Market Perspective (2020-2031)
2.2 Global Generic Drug CRO (Contract Research Organisation) Growth Trends by Region
2.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Generic Drug CRO (Contract Research Organisation) Historic Market Size by Region (2020-2025)
2.2.3 Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031)
2.3 Generic Drug CRO (Contract Research Organisation) Market Dynamics
2.3.1 Generic Drug CRO (Contract Research Organisation) Industry Trends
2.3.2 Generic Drug CRO (Contract Research Organisation) Market Drivers
2.3.3 Generic Drug CRO (Contract Research Organisation) Market Challenges
2.3.4 Generic Drug CRO (Contract Research Organisation) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue
3.1.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue (2020-2025)
3.1.2 Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Players (2020-2025)
3.2 Global Generic Drug CRO (Contract Research Organisation) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Generic Drug CRO (Contract Research Organisation) Revenue
3.4 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio
3.4.1 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug CRO (Contract Research Organisation) Revenue in 2024
3.5 Global Key Players of Generic Drug CRO (Contract Research Organisation) Head office and Area Served
3.6 Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application
3.7 Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Type
4.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Type (2020-2025)
4.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031)
5 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Application
5.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Application (2020-2025)
5.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
6.2 North America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
6.4 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
7.2 Europe Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
7.4 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
8.2 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025)
8.4 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
9.2 Latin America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
9.4 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
10.2 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
10.4 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Worldwide Clinical Trials
11.1.1 Worldwide Clinical Trials Company Details
11.1.2 Worldwide Clinical Trials Business Overview
11.1.3 Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Introduction
11.1.4 Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.1.5 Worldwide Clinical Trials Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Introduction
11.2.4 Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Celerion
11.3.1 Celerion Company Details
11.3.2 Celerion Business Overview
11.3.3 Celerion Generic Drug CRO (Contract Research Organisation) Introduction
11.3.4 Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.3.5 Celerion Recent Development
11.4 Alliance Pharma
11.4.1 Alliance Pharma Company Details
11.4.2 Alliance Pharma Business Overview
11.4.3 Alliance Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.4.4 Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.4.5 Alliance Pharma Recent Development
11.5 Accelsiors
11.5.1 Accelsiors Company Details
11.5.2 Accelsiors Business Overview
11.5.3 Accelsiors Generic Drug CRO (Contract Research Organisation) Introduction
11.5.4 Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.5.5 Accelsiors Recent Development
11.6 Innovind Pharma
11.6.1 Innovind Pharma Company Details
11.6.2 Innovind Pharma Business Overview
11.6.3 Innovind Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.6.4 Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.6.5 Innovind Pharma Recent Development
11.7 Avivia
11.7.1 Avivia Company Details
11.7.2 Avivia Business Overview
11.7.3 Avivia Generic Drug CRO (Contract Research Organisation) Introduction
11.7.4 Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.7.5 Avivia Recent Development
11.8 SUNNOVO
11.8.1 SUNNOVO Company Details
11.8.2 SUNNOVO Business Overview
11.8.3 SUNNOVO Generic Drug CRO (Contract Research Organisation) Introduction
11.8.4 SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.8.5 SUNNOVO Recent Development
11.9 Hangzhou Bio-Sincerity Pharma-Tech
11.9.1 Hangzhou Bio-Sincerity Pharma-Tech Company Details
11.9.2 Hangzhou Bio-Sincerity Pharma-Tech Business Overview
11.9.3 Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.9.4 Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.9.5 Hangzhou Bio-Sincerity Pharma-Tech Recent Development
11.10 Wanbang Biopharma
11.10.1 Wanbang Biopharma Company Details
11.10.2 Wanbang Biopharma Business Overview
11.10.3 Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Introduction
11.10.4 Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.10.5 Wanbang Biopharma Recent Development
11.11 Guangzhou Boji Medical & Biotechnological
11.11.1 Guangzhou Boji Medical & Biotechnological Company Details
11.11.2 Guangzhou Boji Medical & Biotechnological Business Overview
11.11.3 Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Introduction
11.11.4 Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.11.5 Guangzhou Boji Medical & Biotechnological Recent Development
11.12 Xinjiang Bai Hua Cun Pharma Tech
11.12.1 Xinjiang Bai Hua Cun Pharma Tech Company Details
11.12.2 Xinjiang Bai Hua Cun Pharma Tech Business Overview
11.12.3 Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.12.4 Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.12.5 Xinjiang Bai Hua Cun Pharma Tech Recent Development
11.13 Shandong Bestcomm Pharmaceutical
11.13.1 Shandong Bestcomm Pharmaceutical Company Details
11.13.2 Shandong Bestcomm Pharmaceutical Business Overview
11.13.3 Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Introduction
11.13.4 Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.13.5 Shandong Bestcomm Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Research
1.2.3 BE Test
1.3 Market by Application
1.3.1 Global Generic Drug CRO (Contract Research Organisation) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 MAH Customer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug CRO (Contract Research Organisation) Market Perspective (2020-2031)
2.2 Global Generic Drug CRO (Contract Research Organisation) Growth Trends by Region
2.2.1 Global Generic Drug CRO (Contract Research Organisation) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Generic Drug CRO (Contract Research Organisation) Historic Market Size by Region (2020-2025)
2.2.3 Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031)
2.3 Generic Drug CRO (Contract Research Organisation) Market Dynamics
2.3.1 Generic Drug CRO (Contract Research Organisation) Industry Trends
2.3.2 Generic Drug CRO (Contract Research Organisation) Market Drivers
2.3.3 Generic Drug CRO (Contract Research Organisation) Market Challenges
2.3.4 Generic Drug CRO (Contract Research Organisation) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue
3.1.1 Global Top Generic Drug CRO (Contract Research Organisation) Players by Revenue (2020-2025)
3.1.2 Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Players (2020-2025)
3.2 Global Generic Drug CRO (Contract Research Organisation) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Generic Drug CRO (Contract Research Organisation) Revenue
3.4 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio
3.4.1 Global Generic Drug CRO (Contract Research Organisation) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug CRO (Contract Research Organisation) Revenue in 2024
3.5 Global Key Players of Generic Drug CRO (Contract Research Organisation) Head office and Area Served
3.6 Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application
3.7 Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Type
4.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Type (2020-2025)
4.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031)
5 Generic Drug CRO (Contract Research Organisation) Breakdown Data by Application
5.1 Global Generic Drug CRO (Contract Research Organisation) Historic Market Size by Application (2020-2025)
5.2 Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
6.2 North America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
6.4 North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
7.2 Europe Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
7.4 Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
8.2 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025)
8.4 Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
9.2 Latin America Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
9.4 Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size (2020-2031)
10.2 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025)
10.4 Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Worldwide Clinical Trials
11.1.1 Worldwide Clinical Trials Company Details
11.1.2 Worldwide Clinical Trials Business Overview
11.1.3 Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Introduction
11.1.4 Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.1.5 Worldwide Clinical Trials Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Introduction
11.2.4 Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Celerion
11.3.1 Celerion Company Details
11.3.2 Celerion Business Overview
11.3.3 Celerion Generic Drug CRO (Contract Research Organisation) Introduction
11.3.4 Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.3.5 Celerion Recent Development
11.4 Alliance Pharma
11.4.1 Alliance Pharma Company Details
11.4.2 Alliance Pharma Business Overview
11.4.3 Alliance Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.4.4 Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.4.5 Alliance Pharma Recent Development
11.5 Accelsiors
11.5.1 Accelsiors Company Details
11.5.2 Accelsiors Business Overview
11.5.3 Accelsiors Generic Drug CRO (Contract Research Organisation) Introduction
11.5.4 Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.5.5 Accelsiors Recent Development
11.6 Innovind Pharma
11.6.1 Innovind Pharma Company Details
11.6.2 Innovind Pharma Business Overview
11.6.3 Innovind Pharma Generic Drug CRO (Contract Research Organisation) Introduction
11.6.4 Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.6.5 Innovind Pharma Recent Development
11.7 Avivia
11.7.1 Avivia Company Details
11.7.2 Avivia Business Overview
11.7.3 Avivia Generic Drug CRO (Contract Research Organisation) Introduction
11.7.4 Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.7.5 Avivia Recent Development
11.8 SUNNOVO
11.8.1 SUNNOVO Company Details
11.8.2 SUNNOVO Business Overview
11.8.3 SUNNOVO Generic Drug CRO (Contract Research Organisation) Introduction
11.8.4 SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.8.5 SUNNOVO Recent Development
11.9 Hangzhou Bio-Sincerity Pharma-Tech
11.9.1 Hangzhou Bio-Sincerity Pharma-Tech Company Details
11.9.2 Hangzhou Bio-Sincerity Pharma-Tech Business Overview
11.9.3 Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.9.4 Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.9.5 Hangzhou Bio-Sincerity Pharma-Tech Recent Development
11.10 Wanbang Biopharma
11.10.1 Wanbang Biopharma Company Details
11.10.2 Wanbang Biopharma Business Overview
11.10.3 Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Introduction
11.10.4 Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.10.5 Wanbang Biopharma Recent Development
11.11 Guangzhou Boji Medical & Biotechnological
11.11.1 Guangzhou Boji Medical & Biotechnological Company Details
11.11.2 Guangzhou Boji Medical & Biotechnological Business Overview
11.11.3 Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Introduction
11.11.4 Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.11.5 Guangzhou Boji Medical & Biotechnological Recent Development
11.12 Xinjiang Bai Hua Cun Pharma Tech
11.12.1 Xinjiang Bai Hua Cun Pharma Tech Company Details
11.12.2 Xinjiang Bai Hua Cun Pharma Tech Business Overview
11.12.3 Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Introduction
11.12.4 Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.12.5 Xinjiang Bai Hua Cun Pharma Tech Recent Development
11.13 Shandong Bestcomm Pharmaceutical
11.13.1 Shandong Bestcomm Pharmaceutical Company Details
11.13.2 Shandong Bestcomm Pharmaceutical Business Overview
11.13.3 Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Introduction
11.13.4 Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
11.13.5 Shandong Bestcomm Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pharmaceutical Research
Table 3. Key Players of BE Test
Table 4. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2025)
Table 8. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2026-2031)
Table 10. Generic Drug CRO (Contract Research Organisation) Market Trends
Table 11. Generic Drug CRO (Contract Research Organisation) Market Drivers
Table 12. Generic Drug CRO (Contract Research Organisation) Market Challenges
Table 13. Generic Drug CRO (Contract Research Organisation) Market Restraints
Table 14. Global Generic Drug CRO (Contract Research Organisation) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players (2020-2025)
Table 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)
Table 17. Ranking of Global Top Generic Drug CRO (Contract Research Organisation) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Generic Drug CRO (Contract Research Organisation), Headquarters and Area Served
Table 20. Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application
Table 21. Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drug CRO (Contract Research Organisation) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2020-2025)
Table 25. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2026-2031)
Table 27. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2020-2025)
Table 29. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2026-2031)
Table 31. North America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Worldwide Clinical Trials Company Details
Table 47. Worldwide Clinical Trials Business Overview
Table 48. Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Product
Table 49. Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 50. Worldwide Clinical Trials Recent Development
Table 51. Eurofins Scientific Company Details
Table 52. Eurofins Scientific Business Overview
Table 53. Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Product
Table 54. Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 55. Eurofins Scientific Recent Development
Table 56. Celerion Company Details
Table 57. Celerion Business Overview
Table 58. Celerion Generic Drug CRO (Contract Research Organisation) Product
Table 59. Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 60. Celerion Recent Development
Table 61. Alliance Pharma Company Details
Table 62. Alliance Pharma Business Overview
Table 63. Alliance Pharma Generic Drug CRO (Contract Research Organisation) Product
Table 64. Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 65. Alliance Pharma Recent Development
Table 66. Accelsiors Company Details
Table 67. Accelsiors Business Overview
Table 68. Accelsiors Generic Drug CRO (Contract Research Organisation) Product
Table 69. Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 70. Accelsiors Recent Development
Table 71. Innovind Pharma Company Details
Table 72. Innovind Pharma Business Overview
Table 73. Innovind Pharma Generic Drug CRO (Contract Research Organisation) Product
Table 74. Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 75. Innovind Pharma Recent Development
Table 76. Avivia Company Details
Table 77. Avivia Business Overview
Table 78. Avivia Generic Drug CRO (Contract Research Organisation) Product
Table 79. Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 80. Avivia Recent Development
Table 81. SUNNOVO Company Details
Table 82. SUNNOVO Business Overview
Table 83. SUNNOVO Generic Drug CRO (Contract Research Organisation) Product
Table 84. SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 85. SUNNOVO Recent Development
Table 86. Hangzhou Bio-Sincerity Pharma-Tech Company Details
Table 87. Hangzhou Bio-Sincerity Pharma-Tech Business Overview
Table 88. Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Product
Table 89. Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 90. Hangzhou Bio-Sincerity Pharma-Tech Recent Development
Table 91. Wanbang Biopharma Company Details
Table 92. Wanbang Biopharma Business Overview
Table 93. Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Product
Table 94. Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 95. Wanbang Biopharma Recent Development
Table 96. Guangzhou Boji Medical & Biotechnological Company Details
Table 97. Guangzhou Boji Medical & Biotechnological Business Overview
Table 98. Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Product
Table 99. Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 100. Guangzhou Boji Medical & Biotechnological Recent Development
Table 101. Xinjiang Bai Hua Cun Pharma Tech Company Details
Table 102. Xinjiang Bai Hua Cun Pharma Tech Business Overview
Table 103. Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Product
Table 104. Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 105. Xinjiang Bai Hua Cun Pharma Tech Recent Development
Table 106. Shandong Bestcomm Pharmaceutical Company Details
Table 107. Shandong Bestcomm Pharmaceutical Business Overview
Table 108. Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Product
Table 109. Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 110. Shandong Bestcomm Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Generic Drug CRO (Contract Research Organisation) Picture
Figure 2. Global Generic Drug CRO (Contract Research Organisation) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Generic Drug CRO (Contract Research Organisation) Market Share by Type: 2024 VS 2031
Figure 4. Pharmaceutical Research Features
Figure 5. BE Test Features
Figure 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. MAH Customer Case Studies
Figure 10. Others Case Studies
Figure 11. Generic Drug CRO (Contract Research Organisation) Report Years Considered
Figure 12. Global Generic Drug CRO (Contract Research Organisation) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Generic Drug CRO (Contract Research Organisation) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region: 2024 VS 2031
Figure 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players in 2024
Figure 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue in 2024
Figure 18. North America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 20. United States Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 24. Germany Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2031)
Figure 32. China Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 40. Mexico Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 44. Turkey Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Worldwide Clinical Trials Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 48. Eurofins Scientific Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 49. Celerion Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 50. Alliance Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 51. Accelsiors Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 52. Innovind Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 53. Avivia Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 54. SUNNOVO Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 55. Hangzhou Bio-Sincerity Pharma-Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 56. Wanbang Biopharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 57. Guangzhou Boji Medical & Biotechnological Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 58. Xinjiang Bai Hua Cun Pharma Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 59. Shandong Bestcomm Pharmaceutical Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Pharmaceutical Research
Table 3. Key Players of BE Test
Table 4. Global Generic Drug CRO (Contract Research Organisation) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2025)
Table 8. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region (2026-2031)
Table 10. Generic Drug CRO (Contract Research Organisation) Market Trends
Table 11. Generic Drug CRO (Contract Research Organisation) Market Drivers
Table 12. Generic Drug CRO (Contract Research Organisation) Market Challenges
Table 13. Generic Drug CRO (Contract Research Organisation) Market Restraints
Table 14. Global Generic Drug CRO (Contract Research Organisation) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players (2020-2025)
Table 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)
Table 17. Ranking of Global Top Generic Drug CRO (Contract Research Organisation) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Generic Drug CRO (Contract Research Organisation), Headquarters and Area Served
Table 20. Global Key Players of Generic Drug CRO (Contract Research Organisation), Product and Application
Table 21. Global Key Players of Generic Drug CRO (Contract Research Organisation), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Drug CRO (Contract Research Organisation) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2020-2025)
Table 25. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Type (2026-2031)
Table 27. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2020-2025)
Table 29. Global Generic Drug CRO (Contract Research Organisation) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Generic Drug CRO (Contract Research Organisation) Revenue Market Share by Application (2026-2031)
Table 31. North America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Worldwide Clinical Trials Company Details
Table 47. Worldwide Clinical Trials Business Overview
Table 48. Worldwide Clinical Trials Generic Drug CRO (Contract Research Organisation) Product
Table 49. Worldwide Clinical Trials Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 50. Worldwide Clinical Trials Recent Development
Table 51. Eurofins Scientific Company Details
Table 52. Eurofins Scientific Business Overview
Table 53. Eurofins Scientific Generic Drug CRO (Contract Research Organisation) Product
Table 54. Eurofins Scientific Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 55. Eurofins Scientific Recent Development
Table 56. Celerion Company Details
Table 57. Celerion Business Overview
Table 58. Celerion Generic Drug CRO (Contract Research Organisation) Product
Table 59. Celerion Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 60. Celerion Recent Development
Table 61. Alliance Pharma Company Details
Table 62. Alliance Pharma Business Overview
Table 63. Alliance Pharma Generic Drug CRO (Contract Research Organisation) Product
Table 64. Alliance Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 65. Alliance Pharma Recent Development
Table 66. Accelsiors Company Details
Table 67. Accelsiors Business Overview
Table 68. Accelsiors Generic Drug CRO (Contract Research Organisation) Product
Table 69. Accelsiors Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 70. Accelsiors Recent Development
Table 71. Innovind Pharma Company Details
Table 72. Innovind Pharma Business Overview
Table 73. Innovind Pharma Generic Drug CRO (Contract Research Organisation) Product
Table 74. Innovind Pharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 75. Innovind Pharma Recent Development
Table 76. Avivia Company Details
Table 77. Avivia Business Overview
Table 78. Avivia Generic Drug CRO (Contract Research Organisation) Product
Table 79. Avivia Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 80. Avivia Recent Development
Table 81. SUNNOVO Company Details
Table 82. SUNNOVO Business Overview
Table 83. SUNNOVO Generic Drug CRO (Contract Research Organisation) Product
Table 84. SUNNOVO Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 85. SUNNOVO Recent Development
Table 86. Hangzhou Bio-Sincerity Pharma-Tech Company Details
Table 87. Hangzhou Bio-Sincerity Pharma-Tech Business Overview
Table 88. Hangzhou Bio-Sincerity Pharma-Tech Generic Drug CRO (Contract Research Organisation) Product
Table 89. Hangzhou Bio-Sincerity Pharma-Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 90. Hangzhou Bio-Sincerity Pharma-Tech Recent Development
Table 91. Wanbang Biopharma Company Details
Table 92. Wanbang Biopharma Business Overview
Table 93. Wanbang Biopharma Generic Drug CRO (Contract Research Organisation) Product
Table 94. Wanbang Biopharma Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 95. Wanbang Biopharma Recent Development
Table 96. Guangzhou Boji Medical & Biotechnological Company Details
Table 97. Guangzhou Boji Medical & Biotechnological Business Overview
Table 98. Guangzhou Boji Medical & Biotechnological Generic Drug CRO (Contract Research Organisation) Product
Table 99. Guangzhou Boji Medical & Biotechnological Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 100. Guangzhou Boji Medical & Biotechnological Recent Development
Table 101. Xinjiang Bai Hua Cun Pharma Tech Company Details
Table 102. Xinjiang Bai Hua Cun Pharma Tech Business Overview
Table 103. Xinjiang Bai Hua Cun Pharma Tech Generic Drug CRO (Contract Research Organisation) Product
Table 104. Xinjiang Bai Hua Cun Pharma Tech Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 105. Xinjiang Bai Hua Cun Pharma Tech Recent Development
Table 106. Shandong Bestcomm Pharmaceutical Company Details
Table 107. Shandong Bestcomm Pharmaceutical Business Overview
Table 108. Shandong Bestcomm Pharmaceutical Generic Drug CRO (Contract Research Organisation) Product
Table 109. Shandong Bestcomm Pharmaceutical Revenue in Generic Drug CRO (Contract Research Organisation) Business (2020-2025) & (US$ Million)
Table 110. Shandong Bestcomm Pharmaceutical Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Generic Drug CRO (Contract Research Organisation) Picture
Figure 2. Global Generic Drug CRO (Contract Research Organisation) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Generic Drug CRO (Contract Research Organisation) Market Share by Type: 2024 VS 2031
Figure 4. Pharmaceutical Research Features
Figure 5. BE Test Features
Figure 6. Global Generic Drug CRO (Contract Research Organisation) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Generic Drug CRO (Contract Research Organisation) Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. MAH Customer Case Studies
Figure 10. Others Case Studies
Figure 11. Generic Drug CRO (Contract Research Organisation) Report Years Considered
Figure 12. Global Generic Drug CRO (Contract Research Organisation) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Generic Drug CRO (Contract Research Organisation) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Generic Drug CRO (Contract Research Organisation) Market Share by Region: 2024 VS 2031
Figure 15. Global Generic Drug CRO (Contract Research Organisation) Market Share by Players in 2024
Figure 16. Global Top Generic Drug CRO (Contract Research Organisation) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Drug CRO (Contract Research Organisation) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Generic Drug CRO (Contract Research Organisation) Revenue in 2024
Figure 18. North America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 20. United States Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 24. Germany Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Generic Drug CRO (Contract Research Organisation) Market Share by Region (2020-2031)
Figure 32. China Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 40. Mexico Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Generic Drug CRO (Contract Research Organisation) Market Share by Country (2020-2031)
Figure 44. Turkey Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Generic Drug CRO (Contract Research Organisation) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Worldwide Clinical Trials Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 48. Eurofins Scientific Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 49. Celerion Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 50. Alliance Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 51. Accelsiors Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 52. Innovind Pharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 53. Avivia Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 54. SUNNOVO Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 55. Hangzhou Bio-Sincerity Pharma-Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 56. Wanbang Biopharma Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 57. Guangzhou Boji Medical & Biotechnological Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 58. Xinjiang Bai Hua Cun Pharma Tech Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 59. Shandong Bestcomm Pharmaceutical Revenue Growth Rate in Generic Drug CRO (Contract Research Organisation) Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232